APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 56 filers reported holding APYX MEDICAL CORPORATION in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,114,283 | +23.1% | 1,775,793 | 0.0% | 0.60% | +38.5% |
| Q4 2022 | $4,155,355 | -67.6% | 1,775,793 | -37.8% | 0.43% | -64.6% |
| Q3 2022 | $12,818,000 | -22.4% | 2,854,841 | +1.3% | 1.23% | -23.1% |
| Q2 2022 | $16,515,000 | -4.0% | 2,818,341 | +7.0% | 1.60% | -3.7% |
| Q1 2022 | $17,200,000 | -29.5% | 2,634,003 | +38.5% | 1.66% | -25.1% |
| Q4 2021 | $24,384,000 | -6.3% | 1,902,003 | +1.2% | 2.21% | +79.4% |
| Q3 2021 | $26,024,000 | +62.5% | 1,879,003 | +21.0% | 1.23% | +47.5% |
| Q2 2021 | $16,013,000 | +217.5% | 1,553,199 | +197.5% | 0.84% | +140.9% |
| Q1 2021 | $5,043,000 | +39.2% | 522,042 | +3.8% | 0.35% | +7.1% |
| Q4 2020 | $3,622,000 | +58.8% | 503,081 | +3.9% | 0.32% | -12.9% |
| Q3 2020 | $2,281,000 | -9.3% | 484,246 | +6.8% | 0.37% | -11.0% |
| Q2 2020 | $2,516,000 | +97.5% | 453,298 | +27.7% | 0.42% | +42.7% |
| Q1 2020 | $1,274,000 | -36.2% | 354,879 | +50.4% | 0.29% | +69.4% |
| Q4 2019 | $1,996,000 | – | 235,986 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 2,238,515 | $31,003,000 | 4.38% |
| Taylor Frigon Capital Management LLC | 574,199 | $7,953,000 | 2.56% |
| Millrace Asset Group, Inc. | 210,869 | $2,921,000 | 1.82% |
| Cowen Prime Advisors LLC | 251,759 | $3,487,000 | 1.30% |
| COWEN AND COMPANY, LLC | 1,879,003 | $26,024,000 | 1.23% |
| RTW INVESTMENTS, LP | 3,398,279 | $47,066,000 | 0.71% |
| PURA VIDA INVESTMENTS, LLC | 857,018 | $11,870,000 | 0.36% |
| WOLFF WIESE MAGANA LLC | 36,907 | $511,000 | 0.36% |
| EAM Investors, LLC | 128,560 | $1,781,000 | 0.30% |
| WHITE PINE CAPITAL LLC | 57,178 | $792,000 | 0.24% |